CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 97 filers reported holding CYTOKINETICS INC in Q3 2013. The put-call ratio across all filers is 0.27 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $687,000 | -88.1% | 84,158 | -78.9% | 0.00% | -88.5% |
| Q3 2017 | $5,787,000 | -37.6% | 399,077 | -47.9% | 0.03% | -38.1% |
| Q2 2017 | $9,271,000 | +115.5% | 766,263 | +128.9% | 0.04% | +110.0% |
| Q1 2017 | $4,302,000 | +35.6% | 334,806 | +0.2% | 0.02% | +25.0% |
| Q2 2016 | $3,172,000 | -63.2% | 334,284 | -72.7% | 0.02% | -63.6% |
| Q1 2016 | $8,624,000 | -29.5% | 1,223,446 | +4.5% | 0.04% | -31.2% |
| Q4 2015 | $12,239,000 | +1919.6% | 1,170,312 | +1192.6% | 0.06% | +2033.3% |
| Q3 2015 | $606,000 | -31.1% | 90,538 | -30.8% | 0.00% | -25.0% |
| Q2 2015 | $879,000 | +380.3% | 130,814 | +384.5% | 0.00% | +300.0% |
| Q1 2015 | $183,000 | +2187.5% | 27,001 | +2315.1% | 0.00% | – |
| Q3 2013 | $8,000 | – | 1,118 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,106,989 | $14,159,000 | 2.50% |
| Healthcare Value Capital, LLC | 100,000 | $672,000 | 0.71% |
| First Light Asset Management, LLC | 218,792 | $1,470,000 | 0.69% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 435,202 | $2,925,000 | 0.67% |
| TFS CAPITAL LLC | 899,951 | $6,048,000 | 0.59% |
| SPHERA FUNDS MANAGEMENT LTD. | 422,250 | $2,838,000 | 0.28% |
| ALGERT GLOBAL LLC | 73,181 | $492,000 | 0.27% |
| LANSDOWNE PARTNERS (UK) LLP | 2,321,865 | $15,603,000 | 0.13% |
| Leisure Capital Management | 17,567 | $118,000 | 0.12% |
| Rotella Capital Management, Inc. | 15,778 | $106,000 | 0.09% |